Publications by authors named "Alberto Fabbri"

Claim this Profile
T
Therapeutic approach to patients with early stage diffuse large B cell lymphoma: retrospective, multicenter, real-life study of the 'RTL' (regional Tuscan lymphoma network).
Emanuele Cencini, Marianna Palazzo, Dimitri Dardanis, Giulia Lucco Navei, Lara Mannelli, Alberto Fabbri

Leuk Lymphoma· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Health-related quality of life among Hodgkin lymphoma survivors.
Esther Natalie Oliva, Alberto Fabbri, Àrpàd Illès

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant.
Raffaella Guazzo, Anja Fischer, Margherita Vannucchi, Alberto Fabbri, Guido Garosi

Pathol Res Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma.
Emanuele Cencini, Natale Calomino, Anna Sicuranza, Alessandro Gozzetti, Alberto Fabbri

J Chemother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, lenalidomide, dexamethasone (KRD) in BTKi relapsed or refractory mantle cell lymphoma: A phase II study from Fondazione Italiana Linfomi.
Federica Cavallo, Michele Clerico, Elisa Lucchini, Anna Castiglione, Alessandro Re, Alberto Fabbri

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas.
Martina D'Onghia, Maria Mendonça-Sanches, Maria Erasti, Alessandra Cartocci, Laura Calabrese, Alberto Fabbri

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Perspectives for Patients with Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.
Emanuele Cencini, Alberto Fabbri, Elisa Cinotti, Pietro Rubegni, Monica Bocchia

Chemotherapy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients.
Gabriele Perrone, Luigi Rigacci, Giandomenico Roviello, Ida Landini, Alberto Fabbri

Cancer Drug Resist· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study.
Emanuele Cencini, Natale Calomino, Marta Franceschini, Andreea Dragomir, Sara Fredducci, Alberto Fabbri

Hematol Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study.
Martina D'Onghia, Alessandra Cartocci, Laura Calabrese, Daniele Maio, Azzurra Sirchio, Alberto Fabbri

Curr Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Guido Gini, Monica Tani, Alessandra Tucci, Luigi Marcheselli, Marina Cesaretti, Alberto Fabbri

Blood· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study.
Emanuele Cencini, Anna Sicuranza, Alberto Fabbri, Cristina Marzano, Paola Pacelli

Leuk Lymphoma· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone.
Emanuele Cencini, Melania Rocco, Francesco Ghio, Federico Simonetti, Annarosa Cuccaro, Alberto Fabbri

Eur J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Annalisa Arcari, Lugi Rigacci, Alessandra Tucci, Benedetta Puccini, Sara Veronica Usai, Alberto Fabbri

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications.
Emanuele Cencini, Anna Sicuranza, Sara Ciofini, Alberto Fabbri, Monica Bocchia

Curr Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Annalisa Arcari, Valentina Tabanelli, Francesco Merli, Luigi Marcheselli, Michele Merli, Alberto Fabbri

Br J Haematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications.
Claudia Bartolini, Giuseppe Roberto, Anna Girardi, Valentino Moscatelli, Andrea Spini, Alberto Fabbri

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.
Gabriele Perrone, Luigi Rigacci, Sara Urru, Sofya Kovalchuk, Marco Brugia, Alberto Fabbri

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Alessandra Tucci, Francesco Merli, Alberto Fabbri, Luigi Marcheselli, Chiara Pagani

Haematologica· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Alberto Fabbri

Ann Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Alberto Fabbri

Hemasphere· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Emanuele Cencini, Alessandra Tucci, Benedetta Puccini, Federica Cavallo, Stefano Luminari, Alberto Fabbri

Hematol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late haemophagocytic lymphohistiocytosis in a patient treated with Axicabtagene ciloleucel.
Ilaria Cutini, Benedetta Puccini, Alberto Fabbri, Raffaella Santi, Antonella Gozzini

Transpl Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy.
Lisa Argnani, Alessandro Broccoli, Cinzia Pellegrini, Alberto Fabbri, Benedetta Puccini

Hemasphere· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study.
M Christina Cox, Luigi Marcheselli, Giorgia Scafetta, Carlo Visco, Stefan Hohaus, Alberto Fabbri

Leukemia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis